Investor Presentation

116 Investor presentation First six months of 2022 Obesity market share and market growth in EMEA 100% 80% 60% 40% 20% Obesity market growth and Novo Nordisk market share Obesity market size and growth DKK billion ~67% 95% 100% 1.8 0.0 79% 80% 67% 1.1 60% 40% 68% 20% 0.7 EMEA ~95% 79% 0% 0% May May May 2019 NN market share May 2021 Novo Nordisk Others 2022 -NN Growth 2022 -Market growth (right axis) Source: IQVIA, May 2022, Value, MAT; EMEA: Europe, Middle East and Africa; NN: Novo Nordisk

View entire presentation